Loading market dashboard
Telescope Innovations Corp.
TELIFHealthcareOTCCA
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") congratulates its Founder and Chief Technology Officer, Professor Jason Hein, on receiving the 2026 SCI Canada LeSueur Memorial Award from the Society of Chemical Industry ("SCI"). Figure 1. The 2026 LeSeueur Memorial Award Presented to Professor Jason Hein To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/8923/300261_328197891408ab84_001full.jpg Administered by the Society of Chemical Industry, a professional body founded in London in 1881 and incorporated by Royal Charter in 1907, the LeSueur Memorial Award was established in 1955 in honour of Ernest A.
Vancouver, British Columbia--(Newsfile Corp. - June 1, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"),
The Company is actively engaging with pharmaceutical, academic, and investor audiences to strengthen existing and novel partnerships Vancouver, British Columbia--(Newsfile Corp. - May 11, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries. The Company is pleased to report on outreach, marketing, and educational activities, both past and planned for spring 2026.
Revenues are consistent with budget expectations and ahead of Q2 2025 comparative revenues Vancouver, British Columbia--(Newsfile Corp. - April 13, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended February 28, 2026 (Q2 FY2026). The Company generated revenues of approximately $1.6 million during this period, with strong contributions from the development and delivery of Self-Driving Laboratories (SDL), with an adjusted EBITA loss of $0.7 million consistent with management's expectations.
Vancouver, British Columbia--(Newsfile Corp. - March 23, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries. The Company is pleased to announce that Dr. Joel M.
Vancouver, British Columbia--(Newsfile Corp. - March 16, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company")
Vancouver, British Columbia--(Newsfile Corp. - March 12, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) (the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries,has rescoped its previously announced digital marketing agreement dated September 19, 2025, with Gold Standard Media, LLC ("GSM") and its affiliates. In connection with the reduction in scope GSM has refunded the Company $300,000 in previously paid fees so that Telescope is able to use an additional marketing vehicle to support its Investor Marketing activities.
